価格表

在庫・価格 : 2025年04月28日 17時18分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Adipocyte FABP/FABP4, Human, ELISA Kit (96well) <Adipocyte Fatty Acid Binding Protein, ELISA Kit>
データシート
RD191036200R BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥137,000
(未発注)
追加

在庫・価格 : 2025年04月28日 17時18分 現在

Adipocyte FABP/FABP4, Human, ELISA Kit (96well) <Adipocyte Fatty Acid Binding Protein, ELISA Kit>

  • 商品コード:RD191036200R
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥137,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Xu A et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 2006 Mar;52(3):405-13
Xu A et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
2 Bronsky J et al. Adiponectin, adipocyte fatty acid binding protein, and epidermal fatty acid binding protein: proteins newly identified in human breast milk. Clin. Chem. 2006 Sep;52(9):1763-70
Bronsky J et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
3 Stejskal D et al. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur. J. Clin. Invest. 2006 Sep;36(9):621-5
Stejskal D et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
4 Nagaev I et al. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE 2006;1:e31
Nagaev I et al
2006/01/01
PubMed
5 Haider DG et al. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab 2007 Sep;9(5):761-3
Haider DG et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
6 Xu A et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007 Mar;115(12):1537-43
Xu A et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
7 Ben Yahia R et al. [Healthy persons versus patients with diabetes mellitus type 2--choosen parameters in serum and subcutaneous abdominal adipose tissue] Vnitr Lek 2007 Jan;53(1):9, 11-7
Ben Yahia R et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
8 Yeung DC et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007 Aug;27(8):1796-802
Yeung DC et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
9 Cabr辿 A et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007 Nov;195(1):e150-8
Cabr辿 A et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
10 Tso AW et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 2007 Oct;30(10):2667-72
Tso AW et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
11 Karpisek M et al. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia. Eur. J. Clin. Invest. 2007 Aug;37(8):637-42
Karpisek M et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
12 M旦hlig M et al. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur. J. Endocrinol. 2007 Aug;157(2):195-200
M旦hlig M et al
2007/01/01
PubMed
13 Coll B et al. The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis 2008 Jul;199(1):147-53
Coll B et al
2008/01/01
PubMed
14 Reinehr T et al. Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metab. Clin. Exp. 2007 Dec;56(12):1735-41
Reinehr T et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
15 Cabr辿 A et al. Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin. Chem. 2008 Jan;54(1):181-7
Cabr辿 A et al
2008/01/01
PubMed
16 Haluz鱈k MM et al. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment. Physiol Res 2009;58(1):93-9
Haluz鱈k MM et al
2009/01/01
PubMed
17 Zhang X et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008 May;57(5):1246-53
Zhang X et al
2008/01/01
PubMed
18 Sommer G et al. Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin. Endocrinol. (Oxf) 2008 Dec;69(6):901-5
Sommer G et al
2008/01/01
PubMed
19 Cabr辿 A et al. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J. Lipid Res. 2008 Aug;49(8):1746-51
Cabr辿 A et al
2008/01/01
PubMed
20 Fasshauer M et al. Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am. J. Hypertens. 2008 May;21(5):582-6
Fasshauer M et al
2008/01/01
PubMed
21 Engl J et al. A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change? Obesity (Silver Spring) 2008 Aug;16(8):1838-42
Engl J et al
2008/01/01
PubMed
22 Yeung DC et al. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis. Eur. Heart J. 2008 Sep;29(17):2156-63
Yeung DC et al
2008/01/01
PubMed
23 Haluz鱈kov叩 D et al. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 2009;58(4):577-81
Haluz鱈kov叩 D et al
2009/01/01
PubMed
24 Aeberli I et al. The increase of fatty acid-binding protein aP2 in overweight and obese children: interactions with dietary fat and impact on measures of subclinical inflammation. Int J Obes (Lond) 2008 Oct;32(10):1513-20
Aeberli I et al
2008/01/01
PubMed
25 Stejskal D et al. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss. J. Clin. Lab. Anal. 2008;22(5):380-2
Stejskal D et al
2008/01/01
PubMed
26 Koh JH et al. Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 2009 Jan;32(1):147-52
Koh JH et al
2009/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract PubMed
27 Kralisch S et al. Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur. J. Endocrinol. 2009 Jan;160(1):33-8
Kralisch S et al
2009/01/01
PubMed
28 Yeung DC et al. Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabetes Care 2009 Jan;32(1):132-4
Yeung DC et al
2009/01/01
PubMed
29 Rhee EJ et al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur. J. Endocrinol. 2009 Feb;160(2):165-72
Rhee EJ et al
2009/01/01
PubMed
30 Lam DC et al. Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur. Respir. J. 2009 Feb;33(2):346-51
Lam DC et al
2009/01/01
PubMed
31 Sim坦n I et al. Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity (Silver Spring) 2009 Jun;17(6):1124-8
Sim坦n I et al
2009/01/01
PubMed
32 Lui MM et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 2009 Apr;135(4):950-6
Lui MM et al
2009/01/01
PubMed
33 Yeung DC et al. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J. Clin. Endocrinol. Metab. 2009 Jul;94(7):2531-6
Yeung DC et al
2009/01/01
PubMed
34 Yun KE et al. Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children. Metab. Clin. Exp. 2009 Jun;58(6):798-802
Yun KE et al
2009/01/01
PubMed
35 Karakas SE et al. Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers. Metab. Clin. Exp. 2009 Jul;58(7):1002-7
Karakas SE et al
2009/01/01
PubMed
36 Engl J et al. Adipocyte fatty acid binding protein during refeeding of female patients with anorexia nervosa. Eur J Nutr 2009 Oct;48(7):403-8
Engl J et al
2009/01/01
PubMed
37 Bol VV et al. Forced catch-up growth after fetal protein restriction alters the adipose tissue gene expression program leading to obesity in adult mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Aug;297(2):R291-9
Bol VV et al
2009/01/01
PubMed
38 Milner KL et al. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology 2009 Jun;49(6):1926-34
Milner KL et al
2009/01/01
PubMed
39 Shangguan X et al. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin. Chim. Acta 2009 Sep;407(1-2):58-61
Shangguan X et al
2009/01/01
PubMed
40 Lamounier-Zepter V et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ. Res. 2009 Aug;105(4):326-34
Lamounier-Zepter V et al
2009/01/01
PubMed
41 Ciardi C et al. Effect of postprandial lipemia on plasma concentrations of A-FABP, RBP-4 and visfatin. Nutr Metab Cardiovasc Dis 2010 Nov;20(9):662-8
Ciardi C et al
2010/01/01
PubMed
42 Fain JN et al. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring) 2010 May;18(5):890-6
Fain JN et al
2010/01/01
PubMed
43 Hancke K et al. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res. Treat. 2010 Jan;119(2):367-7
Hancke K et al
2010/01/01
PubMed
44 Hsu BG et al. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ. J. 2010 Feb;74(2):327-31
Hsu BG et al
2010/01/01
PubMed
45 Miyoshi T et al. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 2010 Jul;211(1):164-9
Miyoshi T et al
2010/01/01
PubMed
46 Durovcov叩 V et al. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing&#39;s syndrome. Physiol Res 2010;59(6):963-71
Durovcov叩 V et al
2010/01/01
PubMed
47 Jin J et al. Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clin. Chim. Acta 2010 Nov;411(21-22):1761-5
Jin J et al
2010/01/01
PubMed
48 Aragon竪s G et al. Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. Atherosclerosis 2010 Nov;213(1):329-31
Aragon竪s G et al
2010/01/01
PubMed
49 Bagheri R et al. Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am. J. Cardiol. 2010 Oct;106(8):1118-23
Bagheri R et al
2010/01/01
PubMed
50 Horakova D et al. Potential markers of insulin resistance in healthy vs obese and overweight subjects. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010 Sep;154(3):245-9
Horakova D et al
2010/01/01
PubMed
51 Miyoshi T et al. Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart Vessels 2011 Jul;26(4):408-13
Miyoshi T et al
2011/01/01
PubMed
52 Andr辿s Cerezo L et al. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels. Cytokine 2013 Oct;64(1):441-7
Andr辿s Cerezo L et al
2013/01/01
PubMed
53 Aragon竪s G et al. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol 2012 Jun;11:72
Aragon竪s G et al
2012/01/01
PubMed
54 Baessler A et al. Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects. Nutr Diabetes 2014 Feb;4:e106
Baessler A et al
2014/01/01
PubMed
55 Bao Y et al. Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. PLoS ONE 2011 Apr;6(4):e19115
Bao Y et al
2011/01/01
PubMed
56 Breitling LP et al. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur. Heart J. 2012 Nov;33(22):2841-8
Breitling LP et al
2012/01/01
PubMed
57 Burak MF et al. Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes. Sci Transl Med 2015 Dec;7(319):319ra205
Burak MF et al
2015/01/01
PubMed
58 Cabr辿 A et al. FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis 2012 May;222(1):229-34
Cabr辿 A et al
2012/01/01
PubMed
59 Cabr辿 A et al. FABP4 plasma levels are increased in familial combined hyperlipidemia. J. Lipid Res. 2010 May;51(5):1173-8
Cabr辿 A et al
2010/01/01
PubMed
60 Cabr辿 A et al. The APOA5-1131 T&gt;C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes. Nutr Metab Cardiovasc Dis 2010 May;20(4):243-8
Cabr辿 A et al
2010/01/01
PubMed
61 Castro A et al. APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. Atherosclerosis 2010 Mar;209(1):201-5
Castro A et al
2010/01/01
PubMed
62 Chen MC et al. High serum adipocyte fatty acid binding protein level as a potential biomarker of aortic arterial stiffness in hypertensive patients with metabolic syndrome. Clin. Chim. Acta 2017 Oct;473:166-172
Chen MC et al
2017/01/01
PubMed
63 Choi KM et al. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin. Endocrinol. (Oxf) 2009 Apr;70(4):569-74
Choi KM et al
2009/01/01
PubMed
64 Corripio R et al. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study. Eur. J. Endocrinol. 2010 Dec;163(6):887-93
Corripio R et al
2010/01/01
PubMed
65 Creagan ET et al. Phase II clinical trial of the combination VP-16, bleomycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive squamous cell carcinoma. Head Neck Surg ;9(4):223-6
Creagan ET et al
PubMed
66 Danziger J et al. Circulating 25-hydroxyvitamin D is associated with insulin resistance cross-sectionally but not longitudinally in older adults: The Cardiovascular Health Study. Metab. Clin. Exp. 2013 Dec;62(12):1788-94
Danziger J et al
2013/01/01
PubMed
67 Djouss辿 L et al. Plasma Fatty Acid binding protein 4 and risk of sudden cardiac death in older adults. Cardiol Res Pract 2013;2013:181054
Djouss辿 L et al
2013/01/01
PubMed
68 Furuhashi M et al. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS ONE 2011;6(11):e27356
Furuhashi M et al
2011/01/01
PubMed
69 Fuseya T et al. Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population. Cardiovasc Diabetol 2014 Aug;13:126
Fuseya T et al
2014/01/01
PubMed
70 Hao Y et al. Associations of serum adipocyte fatty acid binding protein with body composition and fat distribution in nondiabetic Chinese women. J. Clin. Endocrinol. Metab. 2015 May;100(5):2055-62
Hao Y et al
2015/01/01
PubMed
71 Horakova D et al. Adipocyte fatty acid binding protein and C-reactive protein levels as indicators of insulin resistance development. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011 Dec;155(4):355-9
Horakova D et al
2011/01/01
PubMed
72 Huang CL et al. Serum adipocyte fatty acid-binding protein levels in patients with critical illness are associated with insulin resistance and predict mortality. Crit Care 2013 Feb;17(1):R22
Huang CL et al
2013/01/01
PubMed
73 Huang CL et al. Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease. Cardiovasc Diabetol 2013 Jul;12:105
Huang CL et al
2013/01/01
PubMed
74 Hung CS et al. Evaluation of circulating adipokines and abdominal obesity as predictors of significant myocardial ischemia using gated single-photon emission computed tomography. PLoS ONE 2014;9(5):e97710
Hung CS et al
2014/01/01
PubMed
75 Ishimura S et al. Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS ONE 2013;8(11):e81318
Ishimura S et al
2013/01/01
PubMed
76 Iso T et al. Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise. Clin. Biochem. 2017 Nov;50(16-17):896-902
Iso T et al
2017/01/01
PubMed
77 Iwamoto M et al. Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris. Cardiovasc Diabetol 2012;11:26
Iwamoto M et al
2012/01/01
PubMed
78 Jeon WS et al. Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. Endocrinol Metab (Seoul) 2013 Dec;28(4):283-7
Jeon WS et al
2013/01/01
PubMed
79 Kaess BM et al. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J. Clin. Endocrinol. Metab. 2012 Oct;97(10):E1943-7
Kaess BM et al
2012/01/01
PubMed
80 Kim TN et al. Serum adipocyte fatty acid-binding protein levels are independently associated with sarcopenic obesity. Diabetes Res Clin Pract 2013 Aug;101(2):210-7
Kim TN et al
2013/01/01
PubMed
81 Kim YC et al. Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. J. Nutr. Biochem. 2011 Mar;22(3):289-92
Kim YC et al
2011/01/01
PubMed
82 Kotulak T et al. Cardiac surgery increases serum concentrations of adipocyte fatty acid-binding protein and its mRNA expression in circulating monocytes but not in adipose tissue. Physiol Res 2014;63(1):83-94
Kotulak T et al
2014/01/01
PubMed
83 Kralisch S et al. Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism. Int J Obes (Lond) 2014 Sep;38(9):1251-4
Kralisch S et al
2014/01/01
PubMed
84 L叩zaro I et al. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess. Gynecol Endocrinol 2011 Nov;27(11):935-9
L叩zaro I et al
2011/01/01
PubMed
85 L叩zaro I et al. Lifestyle changes lower FABP4 plasma concentration in patients with cardiovascular risk. Rev Esp Cardiol (Engl Ed) 2012 Feb;65(2):152-7
L叩zaro I et al
2012/01/01
PubMed
86 Liu Y et al. Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr 2014;6(1):25
Liu Y et al
2014/01/01
PubMed
87 Li B et al. Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsia in women with gestational diabetes mellitus. PLoS One 2018;13(2):e0192347
Li B et al
2018/01/01
PubMed
88 Lu L et al. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells. Arterioscler T
Lu L et al
2013/01/01
PubMed
89 Messina S et al. Increased leptin and A-FABP levels in relapsing and progressive forms of MS. BMC Neurol 2013 Nov;13:172
Messina S et al
2013/01/01
PubMed
90 Morieri ML et al. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation. BMC Infect. Dis. 2018 01;18(1):10
Morieri ML et al
2018/01/01
PubMed
91 Ni X et al. Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy. Biomed Res Int 2018;2018:4578140
Ni X et al
2018/01/01
PubMed
92 Novotny D et al. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res 2014;63(2):219-28
Novotny D et al
2014/01/01
PubMed
93 Ortega-Senovilla H et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 2011 Sep;34(9):2061-6
Ortega-Senovilla H et al
2011/01/01
PubMed
94 Pala L et al. Adipokines as possible new predictors of cardiovascular diseases: a case control study. J Nutr Metab 2012;2012:253428
Pala L et al
2012/01/01
PubMed
95 Park SE et al. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines. Nutr Metab Cardiovasc Dis 2012 Jun;22(6):525-32
Park SE et al
2012/01/01
PubMed
96 Queipo-Ortu単o MI et al. FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels. PLoS One 2012;7(11):e48605
Queipo-Ortu単o MI et al
2012/01/01
PubMed
97 Schmilovitz-Weiss H et al. Serum adipocyte fatty acid binding protein in liver transplant recipients and the metabolic syndrome. Ann Hepatol 2012;11(3):343-9
Schmilovitz-Weiss H et al
2012/01/01
PubMed
98 Scifres CM et al. Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia. J Clin Endocrinol Metab 2012 Mar;97(3):E349-56
Scifres CM et al
2012/01/01
PubMed
99 Shen J et al. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J Hepatol 2012 Jun;56(6):1363-70
Shen J et al
2012/01/01
PubMed
100 Siahanidou T et al. Circulating adipocyte fatty acid binding protein levels in healthy preterm infants: Positive correlation with weight gain and total-cholesterol levels. Early Hum Dev 2010 Apr;86(4):197-201
Siahanidou T et al
2010/01/01
PubMed
101 Sovova E et al. Treatment of obstructive sleep apnea with continuous positive airway pressure decreases adipocyte fatty acid-binding protein levels. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012 Mar;156(1):58-62
Sovova E et al
2012/01/01
PubMed
102 Sovova E et al. Possitive correlation between adipocyte fatty acid-binding protein and epicardial fat in patients with a family history of cardiovascular disesase. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2017 Jun;161(2):174-178
Sovova E et al
2017/01/01
PubMed
103 Spartano NL et al. Associations of objective physical activity with insulin sensitivity and circulating adipokine profile: the Framingham Heart Study. Clin Obes 2017 Apr;7(2):59-69
Spartano NL et al
2017/01/01
PubMed
104 Stefanska A et al. A-FABP concentration is more strongly associated with cardiometabolic risk factors and the occurrence of metabolic syndrome in premenopausal than in postmenopausal middle-aged women. Biomed Res Int 2014;2014:645762
Stefanska A et al
2014/01/01
PubMed
105 Stefanska A et al. Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women. Clin Biochem 2011 Mar;44(4):304-6
Stefanska A et al
2011/01/01
PubMed
106 Terra X et al. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 2011 Apr;164(4):539-47
Terra X et al
2011/01/01
PubMed
107 Teunissen CE et al. Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. Alzheimers Dement (Amst) 2016;2:86-94
Teunissen CE et al
2016/01/01
PubMed
108 T旦njes A et al. Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein. Int J Obes (Lond) 2012 Jun;36(6):766-73
T旦njes A et al
2012/01/01
PubMed
109 Toruner F et al. The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2011 Feb;91(2):203-7
Toruner F et al
2011/01/01
PubMed
110 Tsai JP et al. Fasting serum fatty acid-binding protein 4 level positively correlates with metabolic syndrome in hemodialysis patients. Arch Med Res 2010 Oct;41(7):536-40
Tsai JP et al
2010/01/01
PubMed
111 Tuuri AL et al. Systolic blood pressure and fatty acid-binding protein 4 predict pregnancy-induced hypertension in overweight nulliparous women. Placenta 2014 Oct;35(10):797-801
Tuuri AL et al
2014/01/01
PubMed
112 von Eynatten M et al. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 2012 Sep;32(9):2327-35
von Eynatten M et al
2012/01/01
PubMed
113 von Jeinsen B et al. Association of Circulating Adipokines With Echocardiographic Measures of Cardiac Structure and Function in a Community-Based Cohort. J Am Heart Assoc 2018 Jun;7(13)
von Jeinsen B et al
2018/01/01
PubMed
114 Woo YC et al. Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction. PLoS One 2012;7(5):e36868
Woo YC et al
2012/01/01
PubMed
115 Wu LE et al. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol Metab 2014 Jul;3(4):465-73
Wu LE et al
2014/01/01
PubMed
116 Xu A et al. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol 2012 Mar;302(6):H1231-40
Xu A et al
2012/01/01
PubMed
117 Yamada M et al. Serum Fatty Acid Binding Protein 4 Concentrations Are Positively and Independently Associated with Blood Pressure and Abdominal Fat among Parameters in Health Check-Ups in Ordinary Middle-Aged Japanese Males. J Nutr Sci Vitaminol (Tokyo) 2
Yamada M et al
2015/01/01
PubMed
118 Yoo HJ et al. Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab 2011 Mar;96(3):E488-92
Yoo HJ et al
2011/01/01
PubMed
119 Zhou M et al. Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction. Clin Sci (Lond) 2015 Oct;129(7):547-59
Zhou M et al
2015/01/01
PubMed
120 Takagi W et al. Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention. BMC Cardiovasc Disord 2017 Oct;17(1):258
Takagi W et al
2017/01/01
PubMed
121 Zachariah JP et al. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study. J Am Heart Assoc 2017 Jul;6(7)
Zachariah JP et al
2017/01/01
PubMed
122 Manco M et al. Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese Children. Int J Med Sci 2017;14(8):711-720
Manco M et al
2017/01/01
PubMed
123 Guaita-Esteruelas S et al. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients. Oncologist 2017 Nov;22(11):1309-1315
Guaita-Esteruelas S et al
2017/01/01
PubMed
124 Nakamura R et al. Correction: Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study. PLoS One 2019;14(1):e0210932
Nakamura R et al
2019/01/01
PubMed
125 Eichelmann F et al. Methodological utility of chemerin as a novel biomarker of immunity and metabolism. Endocr Connect 2017 Jul;6(5):340-347
Eichelmann F et al
2017/01/01
PubMed
126 Hikage F et al. Fatty acid-binding protein 4 is an independent factor in the pathogenesis of retinal vein occlusion. PLoS One 2021;16(1):e0245763
Hikage F et al
2021/01/01
PubMed
127 Konończuk K et al. Increased Levels of Adipocyte and Epidermal Fatty Acid-Binding Proteins in Acute Lymphoblastic Leukemia Survivors. J Clin Med 2021 Apr;10(8)
Konończuk K et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Xu A et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 2006 Mar;52(3):405-13
    Xu A et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Bronsky J et al. Adiponectin, adipocyte fatty acid binding protein, and epidermal fatty acid binding protein: proteins newly identified in human breast milk. Clin. Chem. 2006 Sep;52(9):1763-70
    Bronsky J et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Stejskal D et al. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur. J. Clin. Invest. 2006 Sep;36(9):621-5
    Stejskal D et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Nagaev I et al. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE 2006;1:e31
    Nagaev I et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Haider DG et al. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab 2007 Sep;9(5):761-3
    Haider DG et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Xu A et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007 Mar;115(12):1537-43
    Xu A et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ben Yahia R et al. [Healthy persons versus patients with diabetes mellitus type 2--choosen parameters in serum and subcutaneous abdominal adipose tissue] Vnitr Lek 2007 Jan;53(1):9, 11-7
    Ben Yahia R et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Yeung DC et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007 Aug;27(8):1796-802
    Yeung DC et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cabr辿 A et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007 Nov;195(1):e150-8
    Cabr辿 A et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Tso AW et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 2007 Oct;30(10):2667-72
    Tso AW et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Karpisek M et al. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia. Eur. J. Clin. Invest. 2007 Aug;37(8):637-42
    Karpisek M et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    M旦hlig M et al. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur. J. Endocrinol. 2007 Aug;157(2):195-200
    M旦hlig M et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Coll B et al. The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis 2008 Jul;199(1):147-53
    Coll B et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Reinehr T et al. Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metab. Clin. Exp. 2007 Dec;56(12):1735-41
    Reinehr T et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Cabr辿 A et al. Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin. Chem. 2008 Jan;54(1):181-7
    Cabr辿 A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Haluz鱈k MM et al. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment. Physiol Res 2009;58(1):93-9
    Haluz鱈k MM et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Zhang X et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008 May;57(5):1246-53
    Zhang X et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Sommer G et al. Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin. Endocrinol. (Oxf) 2008 Dec;69(6):901-5
    Sommer G et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Cabr辿 A et al. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J. Lipid Res. 2008 Aug;49(8):1746-51
    Cabr辿 A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Fasshauer M et al. Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am. J. Hypertens. 2008 May;21(5):582-6
    Fasshauer M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Engl J et al. A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change? Obesity (Silver Spring) 2008 Aug;16(8):1838-42
    Engl J et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Yeung DC et al. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis. Eur. Heart J. 2008 Sep;29(17):2156-63
    Yeung DC et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Haluz鱈kov叩 D et al. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 2009;58(4):577-81
    Haluz鱈kov叩 D et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Aeberli I et al. The increase of fatty acid-binding protein aP2 in overweight and obese children: interactions with dietary fat and impact on measures of subclinical inflammation. Int J Obes (Lond) 2008 Oct;32(10):1513-20
    Aeberli I et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Stejskal D et al. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss. J. Clin. Lab. Anal. 2008;22(5):380-2
    Stejskal D et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Koh JH et al. Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 2009 Jan;32(1):147-52
    Koh JH et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium,Tissue extract
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Kralisch S et al. Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur. J. Endocrinol. 2009 Jan;160(1):33-8
    Kralisch S et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Yeung DC et al. Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabetes Care 2009 Jan;32(1):132-4
    Yeung DC et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Rhee EJ et al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur. J. Endocrinol. 2009 Feb;160(2):165-72
    Rhee EJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Lam DC et al. Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur. Respir. J. 2009 Feb;33(2):346-51
    Lam DC et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Sim坦n I et al. Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Obesity (Silver Spring) 2009 Jun;17(6):1124-8
    Sim坦n I et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Lui MM et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 2009 Apr;135(4):950-6
    Lui MM et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Yeung DC et al. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J. Clin. Endocrinol. Metab. 2009 Jul;94(7):2531-6
    Yeung DC et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Yun KE et al. Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children. Metab. Clin. Exp. 2009 Jun;58(6):798-802
    Yun KE et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Karakas SE et al. Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers. Metab. Clin. Exp. 2009 Jul;58(7):1002-7
    Karakas SE et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Engl J et al. Adipocyte fatty acid binding protein during refeeding of female patients with anorexia nervosa. Eur J Nutr 2009 Oct;48(7):403-8
    Engl J et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Bol VV et al. Forced catch-up growth after fetal protein restriction alters the adipose tissue gene expression program leading to obesity in adult mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Aug;297(2):R291-9
    Bol VV et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Milner KL et al. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology 2009 Jun;49(6):1926-34
    Milner KL et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Shangguan X et al. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin. Chim. Acta 2009 Sep;407(1-2):58-61
    Shangguan X et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Lamounier-Zepter V et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ. Res. 2009 Aug;105(4):326-34
    Lamounier-Zepter V et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Ciardi C et al. Effect of postprandial lipemia on plasma concentrations of A-FABP, RBP-4 and visfatin. Nutr Metab Cardiovasc Dis 2010 Nov;20(9):662-8
    Ciardi C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Fain JN et al. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring) 2010 May;18(5):890-6
    Fain JN et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Hancke K et al. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res. Treat. 2010 Jan;119(2):367-7
    Hancke K et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Hsu BG et al. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ. J. 2010 Feb;74(2):327-31
    Hsu BG et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Miyoshi T et al. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 2010 Jul;211(1):164-9
    Miyoshi T et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Durovcov叩 V et al. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing&#39;s syndrome. Physiol Res 2010;59(6):963-71
    Durovcov叩 V et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Jin J et al. Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clin. Chim. Acta 2010 Nov;411(21-22):1761-5
    Jin J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Aragon竪s G et al. Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. Atherosclerosis 2010 Nov;213(1):329-31
    Aragon竪s G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Bagheri R et al. Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am. J. Cardiol. 2010 Oct;106(8):1118-23
    Bagheri R et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Horakova D et al. Potential markers of insulin resistance in healthy vs obese and overweight subjects. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010 Sep;154(3):245-9
    Horakova D et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Miyoshi T et al. Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart Vessels 2011 Jul;26(4):408-13
    Miyoshi T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Andr辿s Cerezo L et al. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels. Cytokine 2013 Oct;64(1):441-7
    Andr辿s Cerezo L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Aragon竪s G et al. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol 2012 Jun;11:72
    Aragon竪s G et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Baessler A et al. Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects. Nutr Diabetes 2014 Feb;4:e106
    Baessler A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Bao Y et al. Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. PLoS ONE 2011 Apr;6(4):e19115
    Bao Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Breitling LP et al. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur. Heart J. 2012 Nov;33(22):2841-8
    Breitling LP et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Burak MF et al. Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes. Sci Transl Med 2015 Dec;7(319):319ra205
    Burak MF et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Cabr辿 A et al. FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis 2012 May;222(1):229-34
    Cabr辿 A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Cabr辿 A et al. FABP4 plasma levels are increased in familial combined hyperlipidemia. J. Lipid Res. 2010 May;51(5):1173-8
    Cabr辿 A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Cabr辿 A et al. The APOA5-1131 T&gt;C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes. Nutr Metab Cardiovasc Dis 2010 May;20(4):243-8
    Cabr辿 A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Castro A et al. APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. Atherosclerosis 2010 Mar;209(1):201-5
    Castro A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Chen MC et al. High serum adipocyte fatty acid binding protein level as a potential biomarker of aortic arterial stiffness in hypertensive patients with metabolic syndrome. Clin. Chim. Acta 2017 Oct;473:166-172
    Chen MC et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Choi KM et al. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin. Endocrinol. (Oxf) 2009 Apr;70(4):569-74
    Choi KM et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Corripio R et al. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study. Eur. J. Endocrinol. 2010 Dec;163(6):887-93
    Corripio R et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Creagan ET et al. Phase II clinical trial of the combination VP-16, bleomycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive squamous cell carcinoma. Head Neck Surg ;9(4):223-6
    Creagan ET et al
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Danziger J et al. Circulating 25-hydroxyvitamin D is associated with insulin resistance cross-sectionally but not longitudinally in older adults: The Cardiovascular Health Study. Metab. Clin. Exp. 2013 Dec;62(12):1788-94
    Danziger J et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Djouss辿 L et al. Plasma Fatty Acid binding protein 4 and risk of sudden cardiac death in older adults. Cardiol Res Pract 2013;2013:181054
    Djouss辿 L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Furuhashi M et al. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease. PLoS ONE 2011;6(11):e27356
    Furuhashi M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Fuseya T et al. Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population. Cardiovasc Diabetol 2014 Aug;13:126
    Fuseya T et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Hao Y et al. Associations of serum adipocyte fatty acid binding protein with body composition and fat distribution in nondiabetic Chinese women. J. Clin. Endocrinol. Metab. 2015 May;100(5):2055-62
    Hao Y et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Horakova D et al. Adipocyte fatty acid binding protein and C-reactive protein levels as indicators of insulin resistance development. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011 Dec;155(4):355-9
    Horakova D et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Huang CL et al. Serum adipocyte fatty acid-binding protein levels in patients with critical illness are associated with insulin resistance and predict mortality. Crit Care 2013 Feb;17(1):R22
    Huang CL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Huang CL et al. Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease. Cardiovasc Diabetol 2013 Jul;12:105
    Huang CL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Hung CS et al. Evaluation of circulating adipokines and abdominal obesity as predictors of significant myocardial ischemia using gated single-photon emission computed tomography. PLoS ONE 2014;9(5):e97710
    Hung CS et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Ishimura S et al. Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS ONE 2013;8(11):e81318
    Ishimura S et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Iso T et al. Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise. Clin. Biochem. 2017 Nov;50(16-17):896-902
    Iso T et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Iwamoto M et al. Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris. Cardiovasc Diabetol 2012;11:26
    Iwamoto M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Jeon WS et al. Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. Endocrinol Metab (Seoul) 2013 Dec;28(4):283-7
    Jeon WS et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Kaess BM et al. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J. Clin. Endocrinol. Metab. 2012 Oct;97(10):E1943-7
    Kaess BM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Kim TN et al. Serum adipocyte fatty acid-binding protein levels are independently associated with sarcopenic obesity. Diabetes Res Clin Pract 2013 Aug;101(2):210-7
    Kim TN et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Kim YC et al. Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. J. Nutr. Biochem. 2011 Mar;22(3):289-92
    Kim YC et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Kotulak T et al. Cardiac surgery increases serum concentrations of adipocyte fatty acid-binding protein and its mRNA expression in circulating monocytes but not in adipose tissue. Physiol Res 2014;63(1):83-94
    Kotulak T et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Kralisch S et al. Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism. Int J Obes (Lond) 2014 Sep;38(9):1251-4
    Kralisch S et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    L叩zaro I et al. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess. Gynecol Endocrinol 2011 Nov;27(11):935-9
    L叩zaro I et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    L叩zaro I et al. Lifestyle changes lower FABP4 plasma concentration in patients with cardiovascular risk. Rev Esp Cardiol (Engl Ed) 2012 Feb;65(2):152-7
    L叩zaro I et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Liu Y et al. Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr 2014;6(1):25
    Liu Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Li B et al. Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsia in women with gestational diabetes mellitus. PLoS One 2018;13(2):e0192347
    Li B et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Lu L et al. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells. Arterioscler T
    Lu L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Messina S et al. Increased leptin and A-FABP levels in relapsing and progressive forms of MS. BMC Neurol 2013 Nov;13:172
    Messina S et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Morieri ML et al. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation. BMC Infect. Dis. 2018 01;18(1):10
    Morieri ML et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Ni X et al. Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy. Biomed Res Int 2018;2018:4578140
    Ni X et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Novotny D et al. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res 2014;63(2):219-28
    Novotny D et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Ortega-Senovilla H et al. Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 2011 Sep;34(9):2061-6
    Ortega-Senovilla H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Pala L et al. Adipokines as possible new predictors of cardiovascular diseases: a case control study. J Nutr Metab 2012;2012:253428
    Pala L et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Park SE et al. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines. Nutr Metab Cardiovasc Dis 2012 Jun;22(6):525-32
    Park SE et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Queipo-Ortu単o MI et al. FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels. PLoS One 2012;7(11):e48605
    Queipo-Ortu単o MI et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Schmilovitz-Weiss H et al. Serum adipocyte fatty acid binding protein in liver transplant recipients and the metabolic syndrome. Ann Hepatol 2012;11(3):343-9
    Schmilovitz-Weiss H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Scifres CM et al. Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia. J Clin Endocrinol Metab 2012 Mar;97(3):E349-56
    Scifres CM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Shen J et al. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J Hepatol 2012 Jun;56(6):1363-70
    Shen J et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Siahanidou T et al. Circulating adipocyte fatty acid binding protein levels in healthy preterm infants: Positive correlation with weight gain and total-cholesterol levels. Early Hum Dev 2010 Apr;86(4):197-201
    Siahanidou T et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Sovova E et al. Treatment of obstructive sleep apnea with continuous positive airway pressure decreases adipocyte fatty acid-binding protein levels. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012 Mar;156(1):58-62
    Sovova E et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Sovova E et al. Possitive correlation between adipocyte fatty acid-binding protein and epicardial fat in patients with a family history of cardiovascular disesase. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2017 Jun;161(2):174-178
    Sovova E et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Spartano NL et al. Associations of objective physical activity with insulin sensitivity and circulating adipokine profile: the Framingham Heart Study. Clin Obes 2017 Apr;7(2):59-69
    Spartano NL et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Stefanska A et al. A-FABP concentration is more strongly associated with cardiometabolic risk factors and the occurrence of metabolic syndrome in premenopausal than in postmenopausal middle-aged women. Biomed Res Int 2014;2014:645762
    Stefanska A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Stefanska A et al. Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women. Clin Biochem 2011 Mar;44(4):304-6
    Stefanska A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Terra X et al. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 2011 Apr;164(4):539-47
    Terra X et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Teunissen CE et al. Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. Alzheimers Dement (Amst) 2016;2:86-94
    Teunissen CE et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    T旦njes A et al. Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein. Int J Obes (Lond) 2012 Jun;36(6):766-73
    T旦njes A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Toruner F et al. The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2011 Feb;91(2):203-7
    Toruner F et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Tsai JP et al. Fasting serum fatty acid-binding protein 4 level positively correlates with metabolic syndrome in hemodialysis patients. Arch Med Res 2010 Oct;41(7):536-40
    Tsai JP et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Tuuri AL et al. Systolic blood pressure and fatty acid-binding protein 4 predict pregnancy-induced hypertension in overweight nulliparous women. Placenta 2014 Oct;35(10):797-801
    Tuuri AL et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    von Eynatten M et al. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 2012 Sep;32(9):2327-35
    von Eynatten M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    von Jeinsen B et al. Association of Circulating Adipokines With Echocardiographic Measures of Cardiac Structure and Function in a Community-Based Cohort. J Am Heart Assoc 2018 Jun;7(13)
    von Jeinsen B et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Woo YC et al. Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction. PLoS One 2012;7(5):e36868
    Woo YC et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Wu LE et al. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol Metab 2014 Jul;3(4):465-73
    Wu LE et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Xu A et al. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol 2012 Mar;302(6):H1231-40
    Xu A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Yamada M et al. Serum Fatty Acid Binding Protein 4 Concentrations Are Positively and Independently Associated with Blood Pressure and Abdominal Fat among Parameters in Health Check-Ups in Ordinary Middle-Aged Japanese Males. J Nutr Sci Vitaminol (Tokyo) 2
    Yamada M et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Yoo HJ et al. Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab 2011 Mar;96(3):E488-92
    Yoo HJ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Zhou M et al. Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction. Clin Sci (Lond) 2015 Oct;129(7):547-59
    Zhou M et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Takagi W et al. Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention. BMC Cardiovasc Disord 2017 Oct;17(1):258
    Takagi W et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Zachariah JP et al. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study. J Am Heart Assoc 2017 Jul;6(7)
    Zachariah JP et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    Manco M et al. Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese Children. Int J Med Sci 2017;14(8):711-720
    Manco M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Guaita-Esteruelas S et al. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients. Oncologist 2017 Nov;22(11):1309-1315
    Guaita-Esteruelas S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Nakamura R et al. Correction: Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study. PLoS One 2019;14(1):e0210932
    Nakamura R et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    Eichelmann F et al. Methodological utility of chemerin as a novel biomarker of immunity and metabolism. Endocr Connect 2017 Jul;6(5):340-347
    Eichelmann F et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Hikage F et al. Fatty acid-binding protein 4 is an independent factor in the pathogenesis of retinal vein occlusion. PLoS One 2021;16(1):e0245763
    Hikage F et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Konończuk K et al. Increased Levels of Adipocyte and Epidermal Fatty Acid-Binding Proteins in Acute Lymphoblastic Leukemia Survivors. J Clin Med 2021 Apr;10(8)
    Konończuk K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed